Asset Advisors Investment Management, LLC Bristol Myers Squibb CO Transaction History

Asset Advisors Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 20, 2020	SELL	$57.43 - $63.64 $178,435 - $197,729	-3,107 Closed	0 $0
Q2 2020 Jul 21, 2020	BUY	$54.82 - $64.09 $170,325 - $199,127	3,107 New	3,107 $183,000
Q1 2020 Apr 23, 2020	SELL	$46.4 - $67.43 $144,211 - $209,572	-3,108 Closed	0 $0
Q4 2019 Jan 22, 2020	BUY	$49.21 - $64.19 $152,944 - $199,502	3,108 New	3,108 $206,000
Q4 2018 Jan 28, 2019	SELL	$48.76 - $63.23 $177,632 - $230,346	-3,643 Closed	0 $0
Q3 2018 Oct 26, 2018	BUY	$55.19 - $62.25 $201,057 - $226,776	3,643 New	3,643 $226,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Asset Advisors Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Asset Advisors Investment Management, LLC with notifications on news.